Since SAM is the principal donor of the methyl group in multiple physiological processes, MAT1A and MAT2A may participate in various inflammatory diseases, such as experimental autoimmune encephalomyelitis [37], alcoholic hepatitis, non-alcoholic fatty liver diseases [38], and inflammatory bowel diseases [28]. This evidence concerns the gene MAT1A and metabolic dysfunction-associated steatotic liver disease.